Description
Pegaspargase injection is a long-acting enzyme used in the treatment of acute lymphoblastic leukemia (ALL). It depletes asparagine, an amino acid vital for leukemia cell survival. Administered intramuscularly or intravenously, it’s essential in multi-agent chemotherapy protocols, especially in pediatric and adolescent patients.